基础医学与临床 ›› 2009, Vol. 29 ›› Issue (11): 1133-1138.

• 研究论文 • 上一篇    下一篇

脑衰蛋白反应调节蛋白-2参与低氧预适应减轻小鼠脑缺血损伤

张彩艳 封素娟 刘旭 卜祥宁 张楠 郑雅欣 袁晓文 李晓光 李俊发   

  1. 首都医科大学神经生物学系 首都医科大学神经生物学系 首都医科大学疼痛生物医学研究所 首都医科大学神经生物系
  • 收稿日期:2009-07-27 修回日期:2009-08-31 出版日期:2009-11-20 发布日期:2009-11-20
  • 通讯作者: 李俊发

CRMP-2 were involved in hypoxic preconditioning-induced neuroprotection against cerebral ischemic injuries of mice

Cai-yan ZHANG, Su-juan FENG, Xu LIU, Xiang-ning BU, Nan ZHANG, Ya-xin ZHENG, Xiao-wen YUAN, Xiao-guang LI, Jun-fa LI   

  1. Department of Neurobiology,Capital Medical University Institute for Biomedical Sciences of Pain, Department of Neurobiology, Department of Neurobiology and Beijing Institute for Neuroscience, Capital Medical University
  • Received:2009-07-27 Revised:2009-08-31 Online:2009-11-20 Published:2009-11-20
  • Contact: Jun-fa LI

摘要: 目的 研究参与低氧预适应(HPC)的经典型蛋白激酶C II(cPKC II)相互作用的脑衰蛋白反应调节蛋白-2(CRMP-2) 对缺血脑是否有保护作用。方法 成年雄性BALB/c小鼠随机分为常氧(Nor)、HPC、常氧假手术(Nor+sham)、HPC假手术(HPC+sham)、常氧缺血(Nor+I)和HPC缺血(HPC+I)等6组(每组n=6)。应用小鼠整体HPC和脑中动脉梗死(MCAO)致脑局部缺血模型,结合免疫沉淀、双向凝胶电泳和质谱等技术,分离和鉴定与cPKC II相互作用蛋白;利用聚丙烯酰胺凝胶电泳(SDS-PAGE)和蛋白印迹(Western blot)技术,分析CRMP-2磷酸化和蛋白降解水平在脑HPC和缺血中的变化。结果 与Nor组比,HPC鼠脑皮层组织内有10种与cPKC? II相互作用蛋白的表达发生了明显变化,其中CRMP-2在膜相关蛋白组分中的表达量升高,而在胞质蛋白组分中的表达量降低。在脑缺血模型中,与Nor+Sham组相比,Nor+I组小鼠脑皮层缺血核心区(Ic)CRMP-2磷酸化水平明显降低(p<0.05, n=6);与Nor+I组相比,HPC+I组小鼠脑皮层Ic区内CRMP-2磷酸化水平明显增高(p<0.05, n=6)。脑缺血可导致CRMP-2发生水解并伴随着大量55-ku水解片段(BDP)的出现,但与Nor+I组相比,HPC+I组小鼠脑皮层缺血半影区(P)内CRMP-2水解片段减少,水解率明显降低(p<0.05, n=6)。结论 CRMP-2参与了 HPC缓解小鼠脑缺血Ic区内CRMP-2磷酸化水平的降低和减少P区内CRMP-2水解片段从而减轻缺血脑组织的损伤。

关键词: 蛋白激酶CbetaII, 脑衰蛋白反应调节蛋白-2 (CRMP-2), 蛋白质组学, 低氧预适应, 大脑中动脉阻塞

Abstract: Objective To investigate whether conventional protein kinase C (cPKC) II- interacting collapsin response mediator protein-2 (CRMP-2) could provide neuroprotection against cerebral ischemic (I) injuries. Methods Male BALB/c mice were randomly divided into normoxic control (Nor), HPC, Nor+Sham, HPC+Sham, Nor+I and HPC+I groups (n=6 per group). Using our HPC and MCAO mouse models, we applied immunoprecipitation, two-dimensional electrophoresis and mass spectrometry to characterize cPKC II-interacting proteins and combined with SDS-PAGE and Western blot to quantitatively analyze CRMP-2 phosphorylation and degradation levels in the brain of mice after HPC and MCAO. Results Proteomics analysis revealed that the expression levels of 10 cPKC II- interacting proteins changed obviously in cerebral cortex of HPC mice when compared with Nor group. One of these proteins, CRMP-2 protein level increased in particulate fraction and decreased in cytosolic fraction of cerebral cortex of HPC mice. CRMP-2 phosphorylation level in ischemic core (Ic) of cerebral cortex decreased significantly (p<0.05, n=6) as compared with that of Nor+sham group, but CRMP-2 phosphorylation levels in HPC+I group increased significantly compared with that of Nor+I group (p<0.05, n=6). In ischemic cortex, CRMP-2 degradation (proteolysis) was observed as the appearance of 55-ku breakdown products (BDP). However, the CRMP-2 degradation level, BDPs products decreased significantly in penumbra (P) of ischemic cortex from HPC+I group when we compared with that of Nor+I group (p<0.05, n=6). Conclusion CRMP-2 was involved in attenuating the decrease of CRMP-2 phosphorylation in ischemic core and inhibiting its degradation in penumbra of cerebral cortex of mice thereby to lessen the ischemic injuries.

Key words: cPKCbetaII, collapsin response mediator protein-2 (CRMP-2), proteomics, hypoxic preconditioning (HPC), middle cerebral artery occlusion (MCAO)

中图分类号: